‘A Fuse Burning At Both Ends’: German Near-Term Market Outlook For Medtech Industry
Report on medtech’s new hurdles in Europe makes for sobering reading
Executive Summary
Later market launch of innovations and a hit on EBITDA are simultaneously affecting medtech companies in Germany and central Europe as they strive to keep quality uppermost while battling the most frustrating confluence of negative effects on business than most companies have ever seen.